← Back to Search

Intensive therapy for Limited Mobility

N/A
Waitlist Available
Led By Christine Holmstedt, DO
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of hospital admission up until 90 day post hospital discharge follow up
Awards & highlights

Study Summary

This trial will test whether more frequent physical therapy sessions improve outcomes for stroke patients.

Eligible Conditions
  • Limited Mobility
  • Physical Disabilities
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of hospital admission up until 90 day post hospital discharge follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of hospital admission up until 90 day post hospital discharge follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Activity Measure for Post-Acute Care (AMPAC) Score
Change in Modified Rankin Scale
Change in Score of Postural Assessment Stroke Scale (PASS)
+1 more
Secondary outcome measures
Change in National Institutes of Health Stroke Scale (NIHSS) Score
Mean Modified Rankin Scale Score
Mean National Institute of Health Stroke Scale Score (NIHSS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group AExperimental Treatment1 Intervention
The treatment group will receive increased frequency of PT services within the first 3-5 days of admission, followed by daily PT services for the duration of their inpatient stay.
Group II: Group BActive Control1 Intervention
The control group will receive standard care of PT services 3-5 times per week during their hospitalization.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,776 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
269 Previous Clinical Trials
247,012 Total Patients Enrolled
Medical University of South CarolinaLead Sponsor
933 Previous Clinical Trials
7,394,535 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
StrokeJournal
A Very Early Rehabilitation Trial for Stroke (AVERT)
Bernhardt, Julie, Helen Dewey, Amanda Thrift, Janice Collier, and Geoffrey Donnan. 2008. “A Very Early Rehabilitation Trial for Stroke (AVERT)”. Stroke. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/strokeaha.107.492363.
StrokeJournal
Early Mobilization After Stroke
Bernhardt, Julie, Coralie English, Liam Johnson, and Toby B. Cumming. 2015. “Early Mobilization After Stroke”. Stroke. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/strokeaha.114.007434.
International Journal of StrokeJournal
A Very Early Rehabilitation Trial (AVERT)
Bernhardt, Julie, Helen Dewey, Janice Collier, Amanda Thrift, Richard Lindley, Marj Moodie, and Geoffrey Donnan. 2006. “A Very Early Rehabilitation Trial (AVERT)”. International Journal of Stroke. SAGE Publications. doi:10.1111/j.1747-4949.2006.00044.x.
NeurologyJournal
Prespecified Dose-response Analysis for A Very Early Rehabilitation Trial (AVERT)
Bernhardt, Julie, Leonid Churilov, Fiona Ellery, Janice Collier, Jan Chamberlain, Peter Langhorne, Richard I. Lindley, et al.. 2016. “Prespecified Dose-response Analysis for A Very Early Rehabilitation Trial (AVERT)”. Neurology. Ovid Technologies (Wolters Kluwer Health). doi:10.1212/wnl.0000000000002459.
~27 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top